The Peter Attia Drive cover image

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the Interventions Testing Program

The Peter Attia Drive

00:00

Canagliflozin: Insights into Diabetes and Longevity

This chapter discusses the SGLT2 inhibitor Canagliflozin and its role in managing type 2 diabetes, particularly its mechanism of promoting glucose excretion without hypoglycemia. The conversation highlights recent studies showing lifespan increases in male mice, variations in cancer susceptibility between genders, and the implications of glucose on cancer mortality. It emphasizes the challenges of testing longevity drugs and the need for rigorous clinical trials to validate their efficacy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app